Deciphera’s Vimseltinib Could Benefit From Liver Safety, Prescriber Overlap in TGCT

• Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D